Documentos relacionados

1. Interactions of heparin derivatives with recombinant human keratinocyte growth factor: Structural stability and bioactivity effect study.
2. Comprehensive Initiative to Decrease Trauma Venous Thromboembolism.
3. Incidence of DVT and PE after surgical reconstruction for pelvic and acetabular fractures: Does routine duplex scanning affect management?
4. In pregnant women, the pregnancy-adapted YEARS algorithm ruled out PE, with a low rate of VTE at 3 months.
5. The clinical effectiveness and safety of intravenous unfractionated heparin following digital replantation and revascularization: A narrative systematic review.
6. Tumour cell-activated platelets modulate the immunological activity of CD4⁺, CD8⁺, and NK cells, which is efficiently antagonized by heparin.
7. What is a low low-molecular-weight heparin dose?
8. Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin.
9. Combination of engineering the substrate and Ca²⁺ binding domains of heparinase I to improve the catalytic activity.
10. Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration.